LOCUS       NP_000669                572 aa                     PRI 26-FEB-2014
DEFINITION  alpha-1D adrenergic receptor [Homo sapiens].
ACCESSION   NP_000669
VERSION     NP_000669.1  GI:4501957
KEYWORDS    RefSeq.
SOURCE      Homo sapiens (human)
  ORGANISM  Homo sapiens
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
            Catarrhini; Hominidae; Homo.
REFERENCE   1  (residues 1 to 572)
  AUTHORS   Zhao L, Bracken MB and Dewan AT.
  TITLE     Genome-Wide Association Study of Pre-Eclampsia Detects Novel
            Maternal Single Nucleotide Polymorphisms and Copy-Number Variants in
            Subsets of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO)
            Study Cohort
  JOURNAL   Ann. Hum. Genet. (2013) In press
   PUBMED   23551011
  REMARK    Publication Status: Available-Online prior to print
REFERENCE   2  (residues 1 to 572)
  AUTHORS   Ishizuka O, Imamura T, Kurizaki Y, Nishizawa O and Andersson KE.
  TITLE     Male lower urinary tract symptoms and alpha1D-adrenoceptors
  JOURNAL   Int. J. Urol. 20 (1), 73-78 (2013)
   PUBMED   23205498
  REMARK    GeneRIF: alpha(1)(D)-adrenoceptors in the lower urinary tract might
            play an important role in the pathophysiology of lower urinary tract
            disorders. [review] Review article
REFERENCE   3  (residues 1 to 572)
  AUTHORS   Parkman HP, Jacobs MR, Mishra A, Hurdle JA, Sachdeva P, Gaughan JP
            and Krynetskiy E.
  TITLE     Domperidone treatment for gastroparesis: demographic and
            pharmacogenetic characterization of clinical efficacy and
            side-effects
  JOURNAL   Dig. Dis. Sci. 56 (1), 115-124 (2011)
   PUBMED   21063774
  REMARK    GeneRIF: Genetic characteristics associated with response to
            domperidone therapy included polymorphisms in the drug transporter
            gene ABCB1, the potassium channel KCNH2 gene, and
            alpha1D--adrenoceptor ADRA1D gene. GeneRIF: Observational study of
            gene-disease association and gene-environment interaction. (HuGE
            Navigator)
REFERENCE   4  (residues 1 to 572)
  AUTHORS   Lyssand JS, Whiting JL, Lee KS, Kastl R, Wacker JL, Bruchas MR,
            Miyatake M, Langeberg LK, Chavkin C, Scott JD, Gardner RG, Adams ME
            and Hague C.
  TITLE     Alpha-dystrobrevin-1 recruits alpha-catulin to the
            alpha1D-adrenergic receptor/dystrophin-associated protein complex
            signalosome
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 107 (50), 21854-21859 (2010)
   PUBMED   21115837
  REMARK    GeneRIF: Data show that alpha-dystrobrevin-1 recruits alpha-catulin,
            which supersensitizes alpha(1D)-AR functional responses by
            recruiting effector molecules to the signalosome.
REFERENCE   5  (residues 1 to 572)
  AUTHORS   Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B,
            Yusuf S, Gerstein HC, Engert JC and Anand S.
  CONSRTM   DREAM investigators
  TITLE     Variation at the NFATC2 locus increases the risk of
            thiazolidinedione-induced edema in the Diabetes REduction Assessment
            with ramipril and rosiglitazone Medication (DREAM) study
  JOURNAL   Diabetes Care 33 (10), 2250-2253 (2010)
   PUBMED   20628086
  REMARK    GeneRIF: Observational study of gene-disease association,
            gene-environment interaction, and pharmacogenomic / toxicogenomic.
            (HuGE Navigator)
REFERENCE   6  (residues 1 to 572)
  AUTHORS   Esbenshade TA, Hirasawa A, Tsujimoto G, Tanaka T, Yano J, Minneman
            KP and Murphy TJ.
  TITLE     Cloning of the human alpha 1d-adrenergic receptor and inducible
            expression of three human subtypes in SK-N-MC cells
  JOURNAL   Mol. Pharmacol. 47 (5), 977-985 (1995)
   PUBMED   7746284
REFERENCE   7  (residues 1 to 572)
  AUTHORS   Schwinn DA, Johnston GI, Page SO, Mosley MJ, Wilson KH, Worman NP,
            Campbell S, Fidock MD, Furness LM and Parry-Smith DJ.
  CONSRTM   et al
  TITLE     Cloning and pharmacological characterization of human alpha-1
            adrenergic receptors: sequence corrections and direct comparison
            with other species homologues
  JOURNAL   J. Pharmacol. Exp. Ther. 272 (1), 134-142 (1995)
   PUBMED   7815325
REFERENCE   8  (residues 1 to 572)
  AUTHORS   Weinberg DH, Trivedi P, Tan CP, Mitra S, Perkins-Barrow A, Borkowski
            D, Strader CD and Bayne M.
  TITLE     Cloning, expression and characterization of human alpha adrenergic
            receptors alpha 1a, alpha 1b and alpha 1c
  JOURNAL   Biochem. Biophys. Res. Commun. 201 (3), 1296-1304 (1994)
   PUBMED   8024574
REFERENCE   9  (residues 1 to 572)
  AUTHORS   Schwinn DA and Lomasney JW.
  TITLE     Pharmacologic characterization of cloned alpha 1-adrenoceptor
            subtypes: selective antagonists suggest the existence of a fourth
            subtype
  JOURNAL   Eur. J. Pharmacol. 227 (4), 433-436 (1992)
   PUBMED   1359975
REFERENCE   10  (residues 1 to 572)
  AUTHORS   Bruno JF, Whittaker J, Song JF and Berelowitz M.
  TITLE     Molecular cloning and sequencing of a cDNA encoding a human alpha 1A
            adrenergic receptor
  JOURNAL   Biochem. Biophys. Res. Commun. 179 (3), 1485-1490 (1991)
   PUBMED   1656955
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from S70782.1, U03864.1 and
            AL121675.36.
            Summary: Alpha-1-adrenergic receptors (alpha-1-ARs) are members of
            the G protein-coupled receptor superfamily. They activate mitogenic
            responses and regulate growth and proliferation of many cells.
            There are 3 alpha-1-AR subtypes: alpha-1A, -1B and -1D, all of
            which signal through the Gq/11 family of G-proteins and different
            subtypes show different patterns of activation. This gene encodes
            alpha-1D-adrenergic receptor. Similar to alpha-1B-adrenergic
            receptor gene, this gene comprises 2 exons and a single intron that
            interrupts the coding region. [provided by RefSeq, Jul 2008].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            ##Evidence-Data-START##
            Transcript exon combination :: U03864.1, L31772.1 [ECO:0000332]
            RNAseq introns              :: single sample supports all introns
            ERS025081, ERS025084 [ECO:0000348]
            ##Evidence-Data-END##
FEATURES             Location/Qualifiers
     source          1..572
                     /db_xref="taxon:9606"
                     /organism="Homo sapiens"
                     /chromosome="20"
                     /map="20p13"
     Protein         1..572
                     /note="adrenergic, alpha -1D-, receptor; adrenergic,
                     alpha-1A-, receptor; alpha-1D-adrenergic receptor; alpha-1D
                     adrenoceptor; alpha-1D adrenoreceptor; alpha-1A adrenergic
                     receptor; alpha-adrenergic receptor 1a; adrenergic,
                     alpha-1D-, receptor"
                     /product="alpha-1D adrenergic receptor"
                     /calculated_mol_wt="60332"
     Site            96..121
                     /note="propagated from UniProtKB/Swiss-Prot (P25100.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          119..402
                     /note="7 transmembrane receptor (rhodopsin family);
                     pfam00001"
                     /db_xref="CDD:249497"
                     /region_name="7tm_1"
     Site            134..159
                     /note="propagated from UniProtKB/Swiss-Prot (P25100.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            170..192
                     /note="propagated from UniProtKB/Swiss-Prot (P25100.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            214..238
                     /note="propagated from UniProtKB/Swiss-Prot (P25100.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            252..275
                     /note="propagated from UniProtKB/Swiss-Prot (P25100.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            349..373
                     /note="propagated from UniProtKB/Swiss-Prot (P25100.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            381..405
                     /note="propagated from UniProtKB/Swiss-Prot (P25100.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     CDS             1..572
                     /coded_by="NM_000678.3:56..1774"
                     /gene="ADRA1D"
                     /gene_synonym="ADRA1; ADRA1A; ADRA1R; ALPHA1; DAR;
                     dJ779E11.2"
                     /db_xref="CCDS:CCDS13079.1"
                     /db_xref="GeneID:146"
                     /db_xref="HGNC:HGNC:280"
                     /db_xref="HPRD:00079"
                     /db_xref="MIM:104219"
ORIGIN
        1 mtfrdllsvs fegprpdssa ggssaggggg saggaapseg pavggvpgga gggggvvgag
       61 sgednrssag epgsagaggd vngtaavggl vvsaqgvgvg vflaafilma vagnllvils
      121 vacnrhlqtv tnyfivnlav adlllsatvl pfsatmevlg fwafgrafcd vwaavdvlcc
      181 tasilslcti svdryvgvrh slkypaimte rkaaailall wvvalvvsvg pllgwkepvp
      241 pderfcgite eagyavfssv csfylpmavi vvmycrvyvv arsttrslea gvkrergkas
      301 evvlrihcrg aatgadgahg mrsakghtfr sslsvrllkf srekkaaktl aivvgvfvlc
      361 wfpfffvlpl gslfpqlkps egvfkvifwl gyfnscvnpl iypcssrefk raflrllrcq
      421 crrrrrrrpl wrvyghhwra stsglrqdca pssgdappga plaltalpdp dpeppgtpem
      481 qapvasrrkp psafrewrll gpfrrpttql rakvsslshk iraggaqrae aacaqrseve
      541 avslgvphev aegatcqaye ladysnlret di
//
